APA (7th ed.) Citation

MW, L., JS, M., MA, C., LJ, Z., J, L., R, L., . . . LM, S. (2026). Insulin receptor substrate 2 (IRS2) confers resistance to PI3K pathway inhibition in PIK3CA mutant breast cancer. BioRxiv : the preprint server for biology. https://doi.org/10.64898/2026.04.24.720709

Chicago Style (17th ed.) Citation

MW, Lero, Morgan JS, Card MA, Zhu LJ, Li J, Li R, Bui QT, Mohlmann E, and Shaw LM. "Insulin Receptor Substrate 2 (IRS2) Confers Resistance to PI3K Pathway Inhibition in PIK3CA Mutant Breast Cancer." BioRxiv : The Preprint Server for Biology 2026. https://doi.org/10.64898/2026.04.24.720709.

MLA (9th ed.) Citation

MW, Lero, et al. "Insulin Receptor Substrate 2 (IRS2) Confers Resistance to PI3K Pathway Inhibition in PIK3CA Mutant Breast Cancer." BioRxiv : The Preprint Server for Biology, 2026, https://doi.org/10.64898/2026.04.24.720709.